Aytu Biopharma (AYTU) Non Operating Interest Expenses (2010 - 2026)
Aytu Biopharma (AYTU) reported Non Operating Interest Expenses of $383,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026), down 47.5% from $730,000 a year earlier and down 12.2% from the prior quarter.
Powered by 
Analysis
Aytu Biopharma (AYTU) Non Operating Interest Expenses (2010 - 2026) Analysis & Trends
For FY2026 (ended Jun 30, 2026), Aytu Biopharma posted Non Operating Interest Expenses of $1.9 million, down 48.8% from FY2025.
- Non Operating Interest Expenses has a three-year compound annual growth rate of -27.5% (FY2023 to FY2026).
- By fiscal year, Non Operating Interest Expenses came in at $3.7 million in FY2025 (-26.8%), $5.06 million in FY2024 (+1.9%) and $4.96 million in FY2023.
- The fiscal Q4 2026 figure ranks as the lowest quarterly Non Operating Interest Expenses since fiscal Q1 2020.
- Year over year, Non Operating Interest Expenses has now declined in each of the last eight quarters, with an average decline of 37.8% over the last eight quarters.
- Over the past five years, the year-over-year decline in Non Operating Interest Expenses ranged from 14.8% (fiscal Q2 2025) to 51.6% (fiscal Q3 2026).
- Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $436,000 (Q3 2026), $560,000 (Q2 2026) and $516,000 (Q1 2026).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 281.00 Mn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | -462.00 Mn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -435.00 Mn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 673.00 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 247.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Aytu Biopharma | 23.25 Mn | -92.42 Mn | 10.41 Mn | 383,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 383,000.00 |
| Mar 31, 2026 | 436,000.00 |
| Dec 31, 2025 | 560,000.00 |
| Sep 30, 2025 | 516,000.00 |
| Jun 30, 2025 | 730,000.00 |
| Mar 31, 2025 | 900,000.00 |
| Dec 31, 2024 | 1.08 Mn |
| Sep 30, 2024 | 994,000.00 |
| Jun 30, 2024 | 1.25 Mn |
| Mar 31, 2024 | 1.26 Mn |
| Dec 31, 2023 | 1.27 Mn |
| Sep 30, 2023 | 1.28 Mn |
| Sep 30, 2020 | 751,541.00 |
| Jun 30, 2020 | 1.43 Mn |
| Mar 31, 2020 | 538,862.00 |
| Dec 31, 2019 | 446,958.00 |
| Sep 30, 2019 | 195,386.00 |
| Jun 30, 2019 | 136,667.00 |
| Mar 31, 2019 | 194,703.00 |
| Dec 31, 2018 | 127,569.00 |
API Access
Aytu Biopharma Non Operating Interest Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=AYTU&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-operating-interest-expenses", "ticker": "AYTU", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-operating-interest-expenses&ticker=AYTU&period=max&api_key=YOUR_API_KEY");
const data = await res.json();